Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding

Sponsor
Mahmoud Ramadan Hafez (Other)
Overall Status
Recruiting
CT.gov ID
NCT05067296
Collaborator
(none)
1
1
10
0.1

Study Details

Study Description

Brief Summary

Prevalance of Cesarean section niche in patients with abnormal uterine bleeding

Condition or Disease Intervention/Treatment Phase
  • Other: By TVS

Study Design

Study Type:
Observational
Anticipated Enrollment :
1 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Cesarean section niche and patients with abnormal uterine bleeding

Observation by Tvs

Other: By TVS
Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

Abnormal uterine bleeding in patients without Cesarean section niche

Observation by Tvs

Other: By TVS
Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding

Outcome Measures

Primary Outcome Measures

  1. Cesarean section niche in patients with abnormal uterine bleeding [6 months]

    To study relationship between the niche and the abnormal uterine bleeding

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:

Age between 20-40 years old. Non pregnant women. Previous cesarean section (one or more). Presence of abnormal uterine bleeding

Exclusion Criteria:

Virgins Pregnant women. Patients with vaginal delivery. Patients with uterine bleeding with known cause.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Sohag Egypt

Sponsors and Collaborators

  • Mahmoud Ramadan Hafez

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mahmoud Ramadan Hafez, Mahmoud Ramadan Hafez Ahmed, Sohag University
ClinicalTrials.gov Identifier:
NCT05067296
Other Study ID Numbers:
  • Soh-Med-21-09-06
First Posted:
Oct 5, 2021
Last Update Posted:
Oct 5, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2021